In the unmatched samples of the baseline characteristics, significant between group differences were observed in dyslipidemia, diabetes mellitus, heart failure, and ejection fraction < 50%, aspirin, thienopyridine, cilostazol, statin, and insulin. This evidence concerns the gene INS and metabolic syndrome.